The current protocol for Omicron infections dictates that patients are treated with either one monoclonal antibody preparation or one antiviral drug. This is not an optimal strategy but instead, one necessitated by current drug approvals. Unfortunately, it comes with potential dangers of its own.
The Danger Of Covid-19 Monotherapy: Drug Resistance
